4//SEC Filing
Shah Tushar 4
Accession 0001104659-21-005981
CIK 0001819576other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 8:19 PM ET
Size
7.7 KB
Accession
0001104659-21-005981
Insider Transaction Report
Form 4
Liquidia CorpLQDA
Shah Tushar
CMO and Head of R&D
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-19+102,500→ 102,500 totalExercise: $2.97Exp: 2031-01-19→ Common Stock (102,500 underlying) - Award
Performance Stock Units
2021-01-19+51,250→ 51,250 totalExercise: $0.00→ Common Stock (51,250 underlying)
Footnotes (2)
- [F1]The option vests in equal monthly installments over a four-year period, becoming fully vested on January 19, 2025.
- [F2]The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer.
Documents
Issuer
Liquidia Corp
CIK 0001819576
Entity typeother
Related Parties
1- filerCIK 0001487632
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 8:19 PM ET
- Size
- 7.7 KB